Skip to main content
S.D. New York· 7/6/2016

Gillis v. QRX Pharma Ltd.

Citations

  • 197 F. Supp. 3d 557
  • 2016 U.S. Dist. LEXIS 87489
  • 2016 WL 3685095

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • rejecting “implausible” scienter theory because “by its nature, [defendants’] purported scheme could not have continued in perpetuity. Defendants would have known that their efforts [in] feigning likely FDA approval would be revealed, in relatively short order, upon the FDA’s rejection”
  • statements about the EDA approval process “[we]re classically forward-looking, as they address[ed] what defendants expected to occur in the future”

Source: CourtListener parenthetical corpus (CC0).

Judges: Engelmayer

Read full opinion on CourtListener

Cited by

3 cases in this archive cite this case.

Cites

56 cases in this archive are cited by this case; the 20 most cited are listed.

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.